(Alliance News) - ValiRx PLC on Tuesday said subsidiary Cytolytix Ltd has entered an evaluation and material transfer agreement with California-based biotechnology firm Omios Biologics.

The Seattle, Washington-based video game developer and publisher said, despite a "challenging backdrop" with "few signs of modest improvement", its sales are ahead of expectations for the first five ...